Sino Biopharmaceutical Limited (SBHMY)
USD 9.48
(-7.96%)
USD 9.48
(-7.96%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 63.6 Billion CNY | -0.72% |
| 2022 | 64.06 Billion CNY | 5.82% |
| 2021 | 60.54 Billion CNY | 28.24% |
| 2020 | 47.21 Billion CNY | -19.02% |
| 2019 | 58.29 Billion CNY | 17.11% |
| 2018 | 49.78 Billion CNY | 137.78% |
| 2017 | 20.93 Billion CNY | 13.83% |
| 2016 | 18.39 Billion CNY | 33.25% |
| 2015 | 13.8 Billion CNY | 21.86% |
| 2014 | 11.32 Billion CNY | 45.4% |
| 2013 | 7.78 Billion CNY | 23.79% |
| 2012 | 6.29 Billion CNY | 23.5% |
| 2011 | 5.09 Billion CNY | 6.37% |
| 2010 | 4.79 Billion CNY | 44.46% |
| 2009 | 3.31 Billion CNY | 15.26% |
| 2008 | 2.87 Billion CNY | 18.31% |
| 2007 | 2.43 Billion CNY | 9.48% |
| 2006 | 2.22 Billion CNY | -0.3% |
| 2005 | 2.22 Billion CNY | 127.72% |
| 2004 | 978.33 Million CNY | 24.67% |
| 2003 | 784.74 Million CNY | 24.49% |
| 2002 | 630.36 Million CNY | 37.14% |
| 2001 | 459.65 Million CNY | 13.53% |
| 2000 | 404.88 Million CNY | 40.79% |
| 1999 | 287.56 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 66.7 Billion CNY | 0.0% |
| 2024 Q1 | 66.7 Billion CNY | 4.87% |
| 2023 Q3 | 63.6 Billion CNY | -3.1% |
| 2023 Q4 | 63.6 Billion CNY | 0.0% |
| 2023 Q2 | 65.64 Billion CNY | 0.0% |
| 2023 FY | 63.6 Billion CNY | -0.72% |
| 2023 Q1 | 65.64 Billion CNY | 2.46% |
| 2022 Q3 | 64.06 Billion CNY | -1.34% |
| 2022 FY | 64.06 Billion CNY | 5.82% |
| 2022 Q4 | 64.06 Billion CNY | 0.0% |
| 2022 Q1 | 64.93 Billion CNY | 7.25% |
| 2022 Q2 | 64.93 Billion CNY | 0.0% |
| 2021 Q4 | 60.54 Billion CNY | 0.0% |
| 2021 FY | 60.54 Billion CNY | 28.24% |
| 2021 Q1 | 49.15 Billion CNY | 4.11% |
| 2021 Q3 | 60.54 Billion CNY | 7.72% |
| 2021 Q2 | 56.2 Billion CNY | 14.35% |
| 2020 Q3 | 66.2 Billion CNY | -3.14% |
| 2020 FY | 47.21 Billion CNY | -19.02% |
| 2020 Q1 | 66.64 Billion CNY | 14.31% |
| 2020 Q2 | 68.34 Billion CNY | 2.56% |
| 2020 Q4 | 47.21 Billion CNY | -28.69% |
| 2019 Q1 | 51.43 Billion CNY | 3.33% |
| 2019 Q2 | 53.47 Billion CNY | 3.95% |
| 2019 Q4 | 58.29 Billion CNY | 8.42% |
| 2019 FY | 58.29 Billion CNY | 17.11% |
| 2019 Q3 | 53.77 Billion CNY | 0.57% |
| 2018 Q4 | 49.78 Billion CNY | 33.48% |
| 2018 Q3 | 37.29 Billion CNY | 6.6% |
| 2018 Q2 | 34.98 Billion CNY | 1.41% |
| 2018 Q1 | 34.49 Billion CNY | 64.79% |
| 2018 FY | 49.78 Billion CNY | 137.78% |
| 2017 Q2 | 19.6 Billion CNY | -1.49% |
| 2017 Q4 | 20.93 Billion CNY | 1.71% |
| 2017 FY | 20.93 Billion CNY | 13.83% |
| 2017 Q1 | 19.9 Billion CNY | 8.22% |
| 2017 Q3 | 20.58 Billion CNY | 4.98% |
| 2016 Q1 | 15.12 Billion CNY | 9.55% |
| 2016 FY | 18.39 Billion CNY | 33.25% |
| 2016 Q4 | 18.39 Billion CNY | 3.86% |
| 2016 Q3 | 17.7 Billion CNY | 12.86% |
| 2016 Q2 | 15.69 Billion CNY | 3.77% |
| 2015 FY | 13.8 Billion CNY | 21.86% |
| 2015 Q1 | 12.37 Billion CNY | 9.22% |
| 2015 Q2 | 13.46 Billion CNY | 8.85% |
| 2015 Q3 | 14.35 Billion CNY | 6.58% |
| 2015 Q4 | 13.8 Billion CNY | -3.83% |
| 2014 Q3 | 10.78 Billion CNY | 3.44% |
| 2014 FY | 11.32 Billion CNY | 45.4% |
| 2014 Q4 | 11.32 Billion CNY | 5.06% |
| 2014 Q1 | 8.82 Billion CNY | 13.28% |
| 2014 Q2 | 10.42 Billion CNY | 18.11% |
| 2013 FY | 7.78 Billion CNY | 23.79% |
| 2013 Q3 | 7.65 Billion CNY | 6.19% |
| 2013 Q2 | 7.21 Billion CNY | 4.98% |
| 2013 Q1 | 6.87 Billion CNY | 9.19% |
| 2013 Q4 | 7.78 Billion CNY | 1.7% |
| 2012 FY | 6.29 Billion CNY | 23.5% |
| 2012 Q4 | 6.29 Billion CNY | -2.32% |
| 2012 Q3 | 6.44 Billion CNY | 8.95% |
| 2012 Q2 | 5.91 Billion CNY | 0.0% |
| 2011 Q3 | 5.27 Billion CNY | -0.98% |
| 2011 Q2 | 5.32 Billion CNY | 7.87% |
| 2011 Q1 | 4.93 Billion CNY | 0.0% |
| 2011 FY | 5.09 Billion CNY | 6.37% |
| 2011 Q4 | 5.09 Billion CNY | -3.36% |
| 2010 Q2 | 4.65 Billion CNY | 0.0% |
| 2010 FY | 4.79 Billion CNY | 44.46% |
| 2009 FY | 3.31 Billion CNY | 15.26% |
| 2009 Q4 | 3.31 Billion CNY | 0.0% |
| 2008 FY | 2.87 Billion CNY | 18.31% |
| 2007 FY | 2.43 Billion CNY | 9.48% |
| 2006 FY | 2.22 Billion CNY | -0.3% |
| 2005 FY | 2.22 Billion CNY | 127.72% |
| 2004 FY | 978.33 Million CNY | 24.67% |
| 2003 FY | 784.74 Million CNY | 24.49% |
| 2002 FY | 630.36 Million CNY | 37.14% |
| 2001 FY | 459.65 Million CNY | 13.53% |
| 2000 FY | 404.88 Million CNY | 40.79% |
| 1999 FY | 287.56 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 1.87 Million USD | -3386954.498% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -12745360.575% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -24343726.284% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -602560.783% |
| GB Sciences, Inc. | 103.44 Thousand USD | -61488288.662% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -710635.472% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -355731549.888% |
| Skye Bioscience, Inc. | 11.94 Million USD | -532585.341% |
| Zenith Capital Corp. | 7410.00 USD | -858364528.88% |
| Agentix Corp. | 261.39 Thousand USD | -24333016.163% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -3248045.046% |
| Biomind Labs Inc. | 73.81 Thousand USD | -86163108.659% |
| ContraFect Corporation | 20.67 Million USD | -307481.696% |
| CSL Limited | 38.02 Billion USD | -67.284% |
| CytoDyn Inc. | 11.13 Million USD | -571063.964% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -8253363.207% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -227515.298% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -13235545.095% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -87894350.356% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -17986823.423% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -48747.595% |
| SQZ Biotechnologies Company | 107.18 Million USD | -59240.05% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -1919748.736% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -163631.611% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -4441478.051% |
| Mesoblast Limited | 667.9 Million USD | -9423.097% |
| Marizyme, Inc. | 22.01 Million USD | -288814.841% |
| Genus plc | 1.02 Billion USD | -6081.827% |
| Pharming Group N.V. | 462.85 Million USD | -13641.875% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -10144209.25% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -16642664.74% |
| IMV Inc. | 31.33 Million USD | -202891.164% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -1534016.775% |
| MultiCell Technologies, Inc. | 126.22 USD | -50392028896.989% |
| ONE Bio Corp. | 70.08 Million USD | -90653.172% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -49394.062% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -180703.374% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -4389942.192% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -211810.447% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -2315889.091% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -9251698.437% |
| Alpha Cognition Inc. | 2.45 Million USD | -2593717.68% |
| Enzolytics Inc. | 361.7 Million USD | -17484.644% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | -1300.229% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -133237.845% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -9943497.652% |
| Genscript Biotech Corporation | 3.38 Billion USD | -1778.252% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -880882.212% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -83302436.868% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -19764857.459% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -24335622.976% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -6854155.621% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -4682395.566% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -16293536.997% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -6768609.541% |
| Helix BioMedix, Inc. | 3.02 Million USD | -2102478.869% |
| EV Biologics, Inc. | 431.71 Thousand USD | -14732991.584% |
| Q BioMed Inc. | 3.51 Million USD | -1809159.321% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -120589.966% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -14151.299% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | -436737.554% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -2443235.769% |
| HST Global, Inc. | 1526.00 USD | -4168074539.581% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -2753455267.965% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -6437849.749% |
| Halberd Corporation | 10.13 Thousand USD | -627823599.536% |
| Resverlogix Corp. | 8.11 Million USD | -783693.21% |
| Cell Source, Inc. | 195.17 Thousand USD | -32589177.608% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -279201072.029% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.37 Million USD | -862086.056% |
| Ember Therapeutics, Inc. | 184.00 USD | -34567836313.043% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -102179598.946% |
| Kadimastem Ltd | 2.3 Million USD | -2760429.973% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -66492492.283% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -111403583.399% |
| LadRx Corporation | 2.3 Million USD | -2755882.282% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -17986823.423% |
| Affymax, Inc. | 7.44 Million USD | -854458.901% |
| Itoco Inc. | 1.4 Million USD | -4542867.719% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -60004446.226% |
| Mobile Lads Corp. | 52.00 USD | -122316959515.385% |
| International Stem Cell Corporation | 5.39 Million USD | -1179952.301% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 137.63 Thousand USD | -46211570.469% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -44487505.265% |
| Qrons Inc. | 420.00 USD | -15144004423.81% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -16500445.826% |
| SYBLEU INC | 330.46 Thousand USD | -19246791.983% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -11520007.766% |
| Rebus Holdings, Inc. | 5000.00 USD | -1272096280.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -15535171.431% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -423880.401% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -383546.897% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -80512329.114% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -7355805.037% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -846046.322% |
| Neutra Corp. | 2851.00 USD | -2230965140.267% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -196174.823% |
| PureTech Health plc | 693.97 Million USD | -9065.316% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -787957.46% |
| IXICO plc | 15.84 Million USD | -401346.657% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -767888.638% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -61458.611% |
| CSL Limited | 38.02 Billion USD | -67.284% |
| Cellectis S.A. | 333.99 Million USD | -18943.665% |